Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease

This publication has 16 references indexed in Scilit:

• Interleukin-6 gene alleles affect the risk of Alzheimer’s disease and levels of the cytokine in blood and brain
  Neurobiology of Aging, 2003
• Pathological relationships between microglial cell activity and tau and amyloid β protein in patients with Alzheimer's disease
  Neuroscience Letters, 2002
• Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease
  Neuroscience Letters, 2000
• Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population
  Neuroscience Letters, 2000
• The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
  Journal of Clinical Investigation, 1998
• Exploring the etiology of Alzheimer disease using molecular genetics
  Published by American Medical Association (AMA) ,1997
• Glial cytokines in Alzheimer's disease: Review and pathogenic implications
  Human Pathology, 1995
• Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain.
  Proceedings of the National Academy of Sciences, 1995
• Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
  Neuron, 1994
• Clinical diagnosis of Alzheimer's disease
  Neurology, 1984